about us
CEO Message
Leadership
Company Overview
History
Investors
technology
PHENOTYPIC SCREENING
TARGET ID/MOA
PROTEOMICS/BIOMARKER
pDOS
SEOUL-FLUOR
FITGE/TS-FITGE
Molecular Splitter for TPU
R&D
Research Interest
Disease Area
Pipeline
order
Bioprobe
media
Press
News
Gallery
Reference
contact us
Location
Tel. +82-2-887-9090
media
spark biopharma
스파크바이오파마, 추가 파이프라인 임상 1상 식약처 IND 승인
작성자 :
관리자
등록일 : 2023.03.08
조회수
459
링크 :
https://www.medigatenews.com/news/1732172496
목록
